Details for 2011734208
Up to date per 05.04.2026
Actions
Details for 2011734208
Granted/Registered
European Patent
22.05.2013 A
03.06.2015 B1
13.07.2010
US
363725 P
C07D 211/46 20060101AFI20120130BHEP
Owner
Theravance Biopharma R&D IP, LLC901 Gateway Boulevard South San Francisco, CA 94080US
Representative
Representative
Weiser Voith Gugler Patentanwälte PartnerschaftKopfgasse 71130 WienAT
Inventor
COLSON, Pierre-Jean301 Bryant Street 403 San Francisco California 94107US
Information about Fees